Regeneron Pharmaceuticals, Inc.
REGN
Revenue
3.72B
▲173.60M▲4.89%
3 Months ChangeAssets
37.44B
▲1.36B▲3.76%
3 Months ChangeLiabilities
8.12B
▲235.00M▲2.98%
3 Months ChangeFree Cash Flow
1.38B
▲189.20M▲15.91%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0001804220-24-000040
2024-10-31
Form 8-K
ID: 0001804220-24-000038
2024-10-07
Form 8-K
ID: 0001104659-24-106432
2024-08-01
Form 10-Q
ID: 0001804220-24-000028
2024-08-01
Form 8-K
ID: 0001804220-24-000026
2024-07-08
Form 8-K
ID: 0001104659-24-078172
2024-06-20
Form 8-K
ID: 0001104659-24-073372
2024-05-02
Form 10-Q
ID: 0001804220-24-000017
2024-05-02
Form 8-K
ID: 0001804220-24-000015
2024-02-02
Form 8-K
ID: 0001804220-24-000006